Status:
COMPLETED
Lung Ultrasound in COVID-19 Patients
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsors:
Centre Hospitalier Universitaire de Brussels, Brussels, Belgium
Miulli Regional Hospital, Acquaviva delle Fonti, Italy
Conditions:
Covid19
Ultrasound
Eligibility:
All Genders
18+ years
Brief Summary
To assess the prognostic performance of an early global LUS score with respect to the mortality in ICU and duration of ventilation.
Detailed Description
This is an international multicenter cohort study on data collected between March and April 2020. The first available lung ultrasound examination that used a 12-regions approach was used to calculate ...
Eligibility Criteria
Inclusion
- Admitted to an ICU participating in this study between February 1, 2020 and April 30, 2020
- Confirmed with reverse transcriptase polymerase chain reaction (RT-PCR) COVID-19 infection
- Having had received invasive ventilation
- Having had examined at least once with lung ultrasound under invasive ventilation
Exclusion
- Age \<18 years
- First examination with LUS in patients already under extracorporeal membrane oxygenation (ECMO) support.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT04487769
Start Date
June 1 2020
End Date
December 31 2020
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam, Netherlands